[What is safe in the therapy of purulent meningitis?].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D002648:Child; D003453:Cryptococcosis / Q000188:drug therapy; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D008581:Meningitis / Q000188:drug therapy*; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008584:Meningitis, Listeria / Q000188:drug therapy; D008585:Meningitis, Meningococcal / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013292:Streptococcus agalactiae; D014390:Tuberculosis, Meningeal / Q000188:drug therapy
D000900:Anti-Bacterial Agents
Was ist gesichert in der Therapie der Meningitis purulenta?